Mesa Laboratories, Inc. (MLAB) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Artivion, Inc.

IRadimed Corp.

Varex Imaging Corp.

BioLife Solutions, Inc.

Mesa Laboratories, Inc.

Silk Road Medical, Inc.

OrthoPediatrics Corp.

Atrion Corp.

Cytek Biosciences, Inc.

Nevro Corp.

Minerva Surgical, Inc.

Why is Mesa Laboratories, Inc. ?

Company has a low Debt to Equity ratio (avg) at times

INTEREST COVERAGE RATIO(Q) Highest at 410.42
INVENTORY TURNOVER RATIO(HY) Highest at 3.69 times
DEBTORS TURNOVER RATIO(HY) Highest at 6.49 times

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -28.56%, its profits have fallen by -121.6%

High Institutional Holdings at 100%

These investors have better capability and resources to analyse fundamentals of companies than most retail investors.

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -28.56% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Mesa Laboratories, Inc. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Mesa Laboratories, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Mesa Laboratories, Inc.

-37.28%

-0.32

59.59%

S&P 500

13.22%

0.61

20.17%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

14.84%

EBIT Growth (5y)

-2.84%

EBIT to Interest (avg)

1.25

Debt to EBITDA (avg)

3.77

Net Debt to Equity (avg)

0.96

Sales to Capital Employed (avg)

0.55

Tax Ratio

100.00%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

2.60%

ROE (avg)

3.49%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

3.55

EV to EBIT

44.16

EV to EBITDA

17.66

EV to Capital Employed

2.30

EV to Sales

2.99

PEG Ratio

Dividend Yield

ROCE (Latest)

5.20%

ROE (Latest)

-2.97%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bollinger Bands

Bullish

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

No Trend

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

13What is working for the Company

INTEREST COVERAGE RATIO(Q)

Highest at 410.42

INVENTORY TURNOVER RATIO(HY)

Highest at 3.69 times

DEBTORS TURNOVER RATIO(HY)

Highest at 6.49 times

PRE-TAX PROFIT(Q)

Highest at USD 7.01 MM

NET PROFIT(Q)

Highest at USD 4.74 MM

EPS(Q)

Highest at USD 0.85

-11What is not working for the Company

NET PROFIT(HY)

At USD -2.37 MM has Grown at -110.88%

OPERATING CASH FLOW(Y)

Lowest at USD 38.26 MM

CASH AND EQV(HY)

Lowest at USD 48.6 MM

Here's what is working for Mesa Laboratories, Inc.

Pre-Tax Profit

At USD 7.01 MM has Grown at 812.43%

over average net sales of the previous four periods of USD 0.77 MM

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (USD MM)

Net Profit

At USD 4.74 MM has Grown at 523.51%

over average net sales of the previous four periods of USD -1.12 MM

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (USD MM)

Interest Coverage Ratio

Highest at 410.42

in the last five periods

MOJO Watch

The company's ability to manage interest payments is improving

Operating Profit to Interest

Pre-Tax Profit

Highest at USD 7.01 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit

Highest at USD 4.74 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (USD MM)

EPS

Highest at USD 0.85

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Inventory Turnover Ratio

Highest at 3.69 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio

Highest at 6.49 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Mesa Laboratories, Inc.

Operating Cash Flow

Lowest at USD 38.26 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Cash and Eqv

Lowest at USD 48.6 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents